Melissa Muff‐Luett

401 total citations
12 papers, 124 citations indexed

About

Melissa Muff‐Luett is a scholar working on Nephrology, Molecular Biology and Physiology. According to data from OpenAlex, Melissa Muff‐Luett has authored 12 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Melissa Muff‐Luett's work include Renal Diseases and Glomerulopathies (5 papers), Adenosine and Purinergic Signaling (4 papers) and Complement system in diseases (4 papers). Melissa Muff‐Luett is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Adenosine and Purinergic Signaling (4 papers) and Complement system in diseases (4 papers). Melissa Muff‐Luett collaborates with scholars based in United States, Spain and Canada. Melissa Muff‐Luett's co-authors include Larry A. Greenbaum, Teri Jo Mauch, Gloria Fraga, Gema Ariceta, Franz Schaefer, Stephan Ortiz, Hae Il Cheong, Bradley P. Dixon, Seong Heon Kim and Carla Nester and has published in prestigious journals such as JAMA, Blood and Kidney International.

In The Last Decade

Melissa Muff‐Luett

11 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Muff‐Luett United States	5	63	63	31	27	19	12	124
Riinu Pius United Kingdom	6	58 0.9×	51 0.8×	79 2.5×	25 0.9×	8 0.4×	9	174
Y. Saitoh Japan	8	45 0.7×	85 1.3×	11 0.4×	7 0.3×	19 1.0×	23	169
Humphrey Pullon New Zealand	6	25 0.4×	60 1.0×	32 1.0×	9 0.3×	11 0.6×	11	114
E Honsová Czechia	5	62 1.0×	24 0.4×	12 0.4×	11 0.4×	3 0.2×	14	99
Uma Maheshwari India	6	24 0.4×	39 0.6×	8 0.3×	25 0.9×	12 0.6×	19	215
P. Gobert France	7	38 0.6×	25 0.4×	14 0.5×	56 2.1×	3 0.2×	17	111
Yasufumi Ohtsuka Japan	9	99 1.6×	26 0.4×	78 2.5×	10 0.4×	2 0.1×	20	228
Anis Larakeb France	5	42 0.7×	35 0.6×	6 0.2×	13 0.5×	5 0.3×	5	91
Tania Robe-Rybkine France	4	60 1.0×	88 1.4×	51 1.6×	16 0.6×	1 0.1×	5	189
Angela R. Sabo United States	5	64 1.0×	28 0.4×	106 3.4×	49 1.8×	2 0.1×	8	184

Countries citing papers authored by Melissa Muff‐Luett

Since Specialization

Citations

This map shows the geographic impact of Melissa Muff‐Luett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Muff‐Luett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Muff‐Luett more than expected).

Fields of papers citing papers by Melissa Muff‐Luett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Muff‐Luett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Muff‐Luett. The network helps show where Melissa Muff‐Luett may publish in the future.

Co-authorship network of co-authors of Melissa Muff‐Luett

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Muff‐Luett. A scholar is included among the top collaborators of Melissa Muff‐Luett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Muff‐Luett. Melissa Muff‐Luett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gist, Katja M., Natalja L. Stanski, Dana Y. Fuhrman, et al.. (2025). Thrombocytopenia in Children and Young Adults Undergoing Continuous Renal Replacement Therapy: A WE-ROCK Study. Blood Purification. 54(6). 322–333.

Dixon, Bradley P., David Kavanagh, Brigitte Adams, et al.. (2024). Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials. Kidney Medicine. 6(8). 100855–100855. 8 indexed citations

Stanski, Natalja L., Katja M. Gist, Denise Hasson, et al.. (2024). Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK)*. Critical Care Medicine. 52(11). 1686–1699. 4 indexed citations

Mauch, Teri Jo, et al.. (2023). Ethical Concerns for Amnioinfusions to Treat Early-Onset Anhydramnios. JAMA. 329(22). 1913–1913. 2 indexed citations

Constantinescu, Alexandru R., Tej K. Mattoo, William E. Smoyer, et al.. (2022). Clinical presentation and management of nephrotic syndrome in the first year of life: A report from the Pediatric Nephrology Research Consortium. Frontiers in Pediatrics. 10. 988945–988945. 1 indexed citations

Price, Michael E., Kristen Fishler, Melissa Muff‐Luett, et al.. (2022). Variants in AQP11 may result in autosomal recessive bilateral cystic renal dysgenesis. American Journal of Medical Genetics Part A. 191(2). 612–616. 1 indexed citations

Souza, Heidi G. De, Troy Richardson, Donna Claes, et al.. (2021). A comparison of the buttonhole and rope-ladder AVF cannulation techniques and infection rates within the SCOPE collaborative. Pediatric Nephrology. 36(12). 3915–3921. 3 indexed citations

Dixon, Bradley P., Brigitte Adams, David Kavanagh, et al.. (2021). Two-Year Efficacy and Safety of Ravulizumab in Adults and Children with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of Two Phase 3 Studies. Blood. 138(Supplement 1). 769–769. 2 indexed citations

Ariceta, Gema, Bradley P. Dixon, Seong Heon Kim, et al.. (2020). The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment. Kidney International. 100(1). 225–237. 58 indexed citations

10.

Ayoob, Rose, John Barcia, Aftab S. Chishti, et al.. (2020). Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study. Frontiers in Pediatrics. 7. 550–550. 22 indexed citations

11.

Nester, Carla & Melissa Muff‐Luett. (2016). The Genetics of Ultra-Rare Renal Disease. Journal of Pediatric Genetics. 5(1). 33–42. 5 indexed citations

12.

Muff‐Luett, Melissa, et al.. (2014). Kidney-specific expression of GFP by in-utero delivery of pseudotyped adeno-associated virus 9. Molecular Therapy — Methods & Clinical Development. 1. 14014–14014. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact